Tirzepatide Rules The Day On Lilly Earnings Call

Robust Sales In Diabetes And Obesity, Plus Good Data In NASH

 
• By Joseph Haas
  
Lilly office building
Lilly reports soaring sales for Mounjaro and Zepbound • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business